Latest Press Releases

Health News Posted on Saturday, November 9, 2024

Premium Press Releases »

Mind Lab Pro Review: Does This Nootropic Supplement Work?

If life just feels too demanding, an evidence-based nootropic such as Mind Lab Pro may help. Read more here about Mind Lab Pro reviews, ingredients, and price. It’s time to get serious about your professional life or boost your performance, but ...

Read More

Io Therapeutics, Inc., Announces Presentation of Data on its RAR Gamma Agonist Compound IRX5010 Demonstrating Inhibition of Tumor Infiltrating Myeloid derived Suppressor cells, Promotion of Tumor Infiltrating T-cells, and Effective Tumor Growth Inhibition in Murine Models of Breast, Colorectal, and Prostate cancers

SPRING, Texas, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., presented results from studies done in breast, colorectal, and prostate cancer models with the company’s newest anti-cancer compound IRX5010, an agonist of the retinoic ...

Read More

MedSource Labs Announces Groundbreaking Digital Training Assets for IV Catheters

[Minneapolis, Minnesota, Chanhassen], Nov. 07, 2024 (GLOBE NEWSWIRE) -- MedSource Labs and its production partner, Ghost Medical, proudly announce the first training modules designed to improve patient care, comfort and clinician accuracy in ...

Read More

Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis

SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients ...

Read More

ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis

UTRECHT, The Netherlands, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Today, ATNi launches the 5 th edition of the Global Access to Nutrition Index, the largest yet, assessing the world’s 30 largest food and beverage manufacturers and over 52,000 ...

Read More

Nagano Tonic Reviews: Fake Fat Burning Tonic or Satisfied Customer Results?

In the vast world of health and wellness, traditional remedies are gaining increasing attention due to their natural formulations and time-tested benefits. One such emerging supplement is Nagano Tonic , a dietary supplement inspired by the ...

Read More

Duck Creek Technologies Selected to Deliver MDA National's New Policy Admin, Billing and Data Solutions

SYDNEY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has been selected by MDA National (MDAN), an Australia-wide medical ...

Read More

FULFIL Vitamin & Protein Bars Launch in Australia to Shake up the Snack Game

SYDNEY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Brace yourselves, snack lovers! The protein bar that has taken the UK by storm has finally landed in Australia. Say hello to FULFIL Vitamin & Protein Bars, the perfect functional bar for those on the ...

Read More

Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-device to Treat Peripheral Artery Disease

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular Institute ...

Read More

Press Releases »

Welcome to 2024 Chinese Congress of Holistic Integrative Oncology (2024 CCHIO)& 4th International Congress of the Asian Oncology Society (AOS2024)

PR Newswire XI'AN, China, Nov. 9, 2024 XI'AN, China, Nov. 9, 2024 /PRNewswire/ -- On behalf of the organizing committee of the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO), we are very pleased to invite you to attend the ...

Read More

Mind Lab Pro Review: Does This Nootropic Supplement Work?

If life just feels too demanding, an evidence-based nootropic such as Mind Lab Pro may help. Read more here about Mind Lab Pro reviews, ingredients, and price. It’s time to get serious about your professional life or boost your performance, but ...

Read More

Energy Drinks Market to Grow by USD 40.04 Billion from 2023-2027, as Hectic Lifestyles Drive Demand with AI Impact on Market Trends - Technavio

PR Newswire NEW YORK, Nov. 8, 2024 NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global energy drinks market size is estimated to grow by USD 40.04 billion from 2023-2027, according to ...

Read More

Dental Chains Market in the US to Grow by USD 80.4 Billion from 2024-2028, as Rising Oral Cancer Cases Drive Revenue with AI-Powered Market Evolution - Technavio

PR Newswire NEW YORK, Nov. 8, 2024 NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The dental chains market in us size is estimated to grow by USD 80.4 billion from 2024-2028, according to ...

Read More

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

PR Newswire DENVER, Nov. 8, 2024 DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate ...

Read More

Myeloid Therapeutics Announces SITC 2024 Oral Presentation on MT-303, the First in vivo GPC3 Targeting mRNA CAR in Human Studies for Advanced Hepatocellular Carcinoma (HCC)

PR Newswire CAMBRIDGE, Mass., Nov. 8, 2024 - MT-303 programs immune cells directly in patients; the first time an in vivo CAR has been evaluated clinically in HCC - CAMBRIDGE, Mass., Nov. 8, 2024 /PRNewswire/ -- Myeloid Therapeutics, ...

Read More

Canada's Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement

Canada NewsWire KIRKLAND, QC, Nov. 8, 2024 KIRKLAND, QC, Nov. 8, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has recommended WINREVAIR® (sotatercept) for ...

Read More

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

PR Newswire SAN JOSE, Calif., Nov. 8, 2024 SAN JOSE, Calif., Nov. 8, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...

Read More

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024

PR Newswire SINGAPORE, Nov. 8, 2024 SINGAPORE, Nov. 8, 2024 /PRNewswire/ -- HistoIndex, a pioneering leader in artificial intelligence (AI) and stain-free digital pathology, will present its latest research findings and advancements in ...

Read More

Sparrow BioAcoustics and Killick Capital host launch event for Canada's First Cardiac AI Application - Stethophone

PR Newswire ST. JOHN'S, NL, Nov. 8, 2024 Attendees at the event were the first in Canada to see and experience the power of Stethophone firsthand. Stethophone is now available to Canadians on the Apple AppStore.. ST. JOHN'S, NL, Nov. 8, ...

Read More

Cutting-Edge Scans and Diagnostics: Carling Adrenal Center's Guide to Adrenal Health on National Day of Radiology

PR Newswire TAMPA, Fla., Nov. 8, 2024 TAMPA, Fla., Nov. 8, 2024 /PRNewswire/ -- In honor of National Day of Radiology, the Carling Adrenal Center spotlights new radiology techniques for adrenal tumor diagnosis and treatment. These novel ...

Read More

Family Care Center Opens Georgetown Clinic to Address Mental Health Accessibility

PR Newswire GEORGETOWN, Texas, Nov. 8, 2024 GEORGETOWN, Texas, Nov. 8, 2024 /PRNewswire/ -- Texas continues to face significant challenges in providing adequate mental health care, ranking among the lowest in the nation for access to care in ...

Read More

HUYABIO Presents Positive Phase 2 Data on HBI-8000 and Nivolumab Combination for Advanced Melanoma

PR Newswire SAN DIEGO, Nov. 8, 2024 Data supporting the potential for innovative combinations like HBI-8000 and nivolumab to reshape the future of melanoma treatment will be presented at the Society for Immunotherapy of Cancer Annual Meeting ...

Read More

Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024

PR Newswire SEOUL, South Korea, Nov. 8, 2024 Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment outcomes in rare cancer patients receiving pembrolizumab SEOUL, South Korea, Nov. 8, 2024 ...

Read More

Nammi Therapeutics, Inc. Announces First Patient Dosed with QXL138AM in a Phase 1 Study Evaluating Advanced Solid Tumors and Multiple Myeloma

PR Newswire LOS ANGELES, Nov. 8, 2024 LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- Nammi Therapeutics, Inc. (Nammi), a clinical stage immuno-oncology company with a diverse pipeline created with the Masked-Immunocytokine (MIC) and Nammisome ...

Read More

Robles BioCeutics LLC Collaborates with BioCentrium to Explore the Molecular Mechanisms Behind Glowselle™ Stem Cell Activator

PR Newswire SAN DIEGO, Nov. 8, 2024 SAN DIEGO, Nov. 8, 2024 /PRNewswire/ -- Robles BioCeutics LLC, a regenerative dermatology company, is pleased to announce a new collaboration with BioCentrium aimed at advancing research into the molecular ...

Read More

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

PR Newswire PHILADELPHIA, Nov. 8, 2024 New findings showcase the potential of in vivo CAR-M technology as an effective, off-the-shelf treatment for hepatocellular carcinoma (HCC) PHILADELPHIA, Nov. 8, 2024 /PRNewswire/ -- Carisma ...

Read More

SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M17D1 in Advanced Solid Tumors

PR Newswire REDMOND, Wash., Nov. 8, 2024 REDMOND, Wash., Nov. 8, 2024 /PRNewswire/ -- SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

Read More

FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer

PR Newswire CAESAREA, Israel, Nov. 8, 2024 FDA decision on marketing authorization expected in the first quarter of 2025 CAESAREA, Israel, Nov. 8, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or ...

Read More

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma

PR Newswire RARITAN, N.J., Nov. 8, 2024 If approved, DARZALEX FASPRO® will become the first treatment option for patients with smoldering multiple myeloma at high-risk of developing multiple myeloma, offering a novel approach to treat before ...

Read More

Step up, show up: Dubai's annual walkathon WeWalk returns in fight against diabetes

PR Newswire DUBAI, UAE, Nov. 8, 2024 DUBAI, UAE  , Nov. 8, 2024 /PRNewswire/ -- Mark your calendars for a day of collective action and community spirit as WeWalk returns for its fifth edition on Saturday, 16 November 2024 to raise awareness ...

Read More

Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

PR Newswire SHANGHAI, Nov. 8, 2024 The submission is supported by data from the pivotal WU-KONG1 Part B study, which featured in an oral session at the 2024 ASCO Annual Meeting Sunvozertinib is the world's first and only oral drug ...

Read More

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

PR Newswire CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 8, 2024 CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 8, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global ...

Read More

Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial

PR Newswire OXFORD, England, Nov. 8, 2024 OXFORD, England, Nov. 8, 2024 /PRNewswire/ -- Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably ...

Read More

InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC

PR Newswire NANJING, China, Nov. 7, 2024 NANJING, China, Nov. 7, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, is presenting ...

Read More

JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma

PR Newswire SHANGHAI and NANJING, China and SAN JOSE, Calif., Nov. 7, 2024 —— The Phase 1b/2 study FUMANBA-1 demonstrates Equecabtagene Autoleucel led to deep and durable responses in patients with R/RMM —— The data shows the overall ...

Read More

Global Respiratory Disease Testing Market to Grow at a CAGR of ~4% by 2030 | DelveInsight

PR Newswire LAS VEGAS, Nov. 7, 2024 The growing demand for respiratory disease testing is largely driven by the increasing global prevalence of respiratory disorders. Furthermore, the rising risk factors linked to these disorders, along with ...

Read More

Born Free USA Expresses Concern for 43 Rhesus Macaques Escaped from South Carolina Laboratory, Urges Laboratory to Rehome the Monkeys to Sanctuary

PR Newswire COTULLA, Texas, Nov. 7, 2024 COTULLA, Texas, Nov. 7, 2024 /PRNewswire/ -- Following the disturbing news that 43 monkeys have escaped the Alpha Genesis research facility in South Carolina, Born Free USA, leading animal nonprofit, ...

Read More

Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market Landscape - Technavio

PR Newswire NEW YORK, Nov. 7, 2024 NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global myopia and presbyopia treatment market size is estimated to grow by USD 9.76 billion from 2024-2028, according ...

Read More

Sleep Apnea Implants Market to Grow by USD 401.75 Million from 2024-2028, as Rising Sleep Apnea and Respiratory Disorders Drive Revenue with AI Impact on Trends - Technavio

PR Newswire NEW YORK, Nov. 7, 2024 NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global sleep apnea implants market  size is estimated to grow by USD 401.75 million from 2024-2028, according to ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.